Early Treatment with Metformin Improves Neurological Outcomes in Lafora Disease-Reference-Cited by-同舟云学术

Early Treatment with Metformin Improves Neurological Outcomes in Lafora Disease

Published:2022-10-27 Issue:1 Volume:20 Page:230-244
ISSN:1933-7213
Container-title:Neurotherapeutics
language:en
Short-container-title:Neurotherapeutics

Author:

Burgos Daniel F.,Machío-Castello María,Iglesias-Cabeza Nerea,Giráldez Beatriz G.,González-Fernández Juan,Sánchez-Martín Gema,Sánchez Marina P.,Serratosa José M.

Funder

National Institute of Neurological Disorders and Stroke

Ministerio de Ciencia e Innovación

Fundación Tatiana Pérez de Guzmán el Bueno

Centro de Investigación Biomédica en Red Enfermedades Raras

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Neurology (clinical),Pharmacology

Link

https://link.springer.com/content/pdf/10.1007/s13311-022-01304-w.pdf

Reference50 articles.

1. Pondrelli F, Muccioli L, Licchetta L, Mostacci B, Zenesini C, Tinuper P, et al. Natural history of Lafora disease: a prognostic systematic review and individual participant data meta-analysis. Orphanet J Rare Dis. 2021;16(1):362.

2. Van H, De Jager H. Progressive myoclonus epilepsy with lafora bodies. Clinical-Pathological Features. Epilepsia. 1963;4:95–119.

3. Berkovic SF, Andermann F, Carpenter S, Wolfe LS. Progressive myoclonus epilepsies: specific causes and diagnosis. N Engl J Med. 1986;315(5):296–305.

4. Berkovic SF, So NK, Andermann F. Progressive myoclonus epilepsies: clinical and neurophysiological diagnosis. J Clin Neurophysiol. 1991;8(3):261–74.

5. Minassian BA, Lee JR, Herbrick JA, Huizenga J, Soder S, Mungall AJ, et al. Mutations in a gene encoding a novel protein tyrosine phosphatase cause progressive myoclonus epilepsy. Nat Genet. 1998;20(2):171–4.

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neurological glycogen storage diseases and emerging therapeutics;Neurotherapeutics;2024-09

2. Exploring the clinical connections between epilepsy and diabetes mellitus: Promising therapeutic strategies utilizing agmatine and metformin;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-07-27

3. Gene therapy for Lafora disease in the Epm2a mouse model;Molecular Therapy;2024-07

4. Neuroinflammation and Epilepsy: From Pathophysiology to Therapies Based on Repurposing Drugs;International Journal of Molecular Sciences;2024-04-09

5. Lafora progressive myoclonus epilepsy: Disease mechanism and therapeutic attempts;Journal of Biosciences;2024-01-20